my point in saying this is that we know this is true. We know that in the medical health field, if there are some great results that are coming that could be patentable or provide treatments--that the medical sector of our economy is growing as a percentage of the gross national product, that I think is somewhere around 15 percent now, growing faster, that there is a heavy investment in medical research taking place, we know that in the pharmaceutical industry, we know that in the medical treatment areas that is taking place. So why is that not happening in embryonic stem cells? The reason is because it is not producing any results. Instead, we have health ministries and corporations going abroad to make these investments in the adult field when they feel like there is not sufficient interest here taking place. That should tell us something; that is, the private sector is not putting money in. Indeed, the private-sector research is waning. These are all indicators that we ought to be looking at and asking ourselves: What is taking place?
Sam Brownback: “my point in saying this is that we know this is true. We know that in the medical health field, if there are some great…”
Editor's note · Context
Discussing the lack of private sector investment in embryonic stem cell research.
Share
More from Sam Brownback
I wanted to engage my colleague from North Dakota because there is a strong base of bipartisan support to do this, and I also believe there is a strong majority community across America that supports this. Don't get it out there so wild…
I would continue the policies that have been done in the prior administration in working on these international issues.
I have served here a period of 14 years, which has been a wonderful chance to be able to serve the people of Kansas--the people of the United States. I love this body and I love this country. A lot of folks, when they leave, talk about…
we have to get more focus on this by a broader cross-section, or we will not be effective in this.





